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In last years, Campylobacter spp has become one of the most 
important foodborne pathogens even in high-income countries. 
Particularly, in Europe, Campylobacteriosis is, since 2005, the 
foodborne disease most frequently notified and the second in USA, 
preceded by the infection due to Salmonella spp. Campylobacter 
spp is a commensal microorganism of the gastrointestinal tract 
of many wild animals (birds such as ducks and gulls), farm ani-
mals (cattle and pigs) and companion animals (such as dogs and 
cats) and it is responsible for zoonoses. The transmission occurs 
via the fecal-oral route through ingestion of contaminated food 
and water. The disease varied from a watery diarrhea to a severe 
inflammatory diarrhea with abdominal pain and fever and can be 
burdened by some complications. The main recognized sequelae 
are Guillain-Barré Syndrome (GBS), the Reactive Arthritis (REA) 
and irritable bowel syndrome (IBS). Recently, many cases of 
Campylobacter spp isolated from human infections, showed an 
important resistance to various antibiotics such as tetracyclines 
and fluoroquinolones. For these reasons, the prevention of this 
infection plays an essential role. Many preventive measures exist 
to limit the transmission of the pathogens and the subsequent dis-
ease such as the health surveillance, the vaccination of the poul-
try and the correct food hygiene throughout the entire production 
chain. A global surveillance of Campylobacteriosis is desirable 
and should include data from all countries, including notifications 
of cases and the microbiological data typing of strains isolated 
from both human and animal cases.
Review
Campylobacter: from microbiology to prevention
A. FACCIOLÀ, R. RISO, E. AVVENTUROSO, G. VISALLI, S.A. DELIA, P. LAGANÀ
Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Italy
Keywords
Campylobacter • Foodborne pathogens • Epidemiology • Prevention
Summary
Introduction
The bacteria belonging to the genus Campylobacter 
have long been recognized among the most common 
responsible agents of enteritis and gastroenteritis in hu-
mans, both among adults and in pediatric patients [1-3]. 
In recent years, in high-income countries, cases of Cam-
pylobacteriosis have exceeded those caused by classic 
enteric bacteria. The micro-organism is isolated from 
patients with infections of the alimentary tract with a 
frequency of about 3-4 times higher than in Salmonella 
or Escherichia coli [4]. In low- and middle-income the 
data, although poor, suggests that the rate of infection 
by Campylobacter has increased in recent years [5]. It is 
often difficult to trace the sources of exposure to Cam-
pylobacter, this is due to the sporadic nature of the infec-
tion and the important role of cross-contamination. For 
these reasons, over the past decade, many countries have 
put in place a number of important preventive measures 
to avoid these food-borne infections [6]. In addition, re-
cent scientific advances, such as the complete sequenc-
ing of the genome of the microorganism, the new find-
ings on causes of the infection and the recognition of the 
role of immunity in protecting against Campylobacter 
infections [7], exploitable process for the development 
point of the appropriate vaccine have led to a better un-
derstanding of the pathogenesis [8] and have helped to 
guide the Assessment and Management Risk along the 
chain “farm-to-table”. 
Nevertheless, Campylobacteriosis remains a difficult 
disease to prevent and infection epidemiological trend 
continues to remain high throughout the world.
Microbiology
The taxonomy of the genus Campylobacter has been 
extensively revised; currently the immediate family is 
that of Campylobacteriaceae, which includes three dis-
tinct genera: Campylobacter, Arcobacter and Helico-
bacter  [9]. The genus Campylobacter includes 22 spe-
cies, of which the best known are C. jejuni and C. coli, the 
main responsible of gastroenteritis in humans, although 
other species such as C. concisus, C. upsaliensis, C. 
ureolyticus, C. hyointestinalis and C. sputorum, species 
now considered “emerging”, have been associated with 
gastroenteritis and periodontitis [9, 10]. All these species 
normally colonize different apparatuses of domestic or 
wild animals and can be found in many foods of animal 
origin [10]. The genus Campylobacter comprises gram-
negative microorganisms, non-sporeforming and with 
variable dimensions, with a length between 0.5 and 5 
μm and a width comprised between 0.2 to 0.9 μm [11]. 
Most of the species is mobile and is characterized by 
a spiral movement caused by a polar flagellum present 
on one or both ends of the cell. The only exceptions are 
Campylobacter gracilis, which is motionless, and Cam-
pylobacter showae that has multiple flagella  [12]. The 
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DNA is around 1.6-1.7 Mbps and is rich in adenine and 
thymine; GC ratio is, in fact, about 30% [13-15]. From 
a metabolic point of view it is of micro-aerofili bacteria 
that, therefore, survive and grow best in an environment 
characterized by a low oxygen tension (5% O2, 10% 
CO2, and 85% N2) [9, 16]. 
All species, except C. gracilis, synthesize the oxidase 
enzyme. Not ferment nor oxidize carbohydrates but they 
get energy from amino acids or tricarboxylic acid [12]. 
Campylobacter species is able to grow at pH between 
6.5 and 7.5 and at temperatures between 37° and 42° C. 
For this reason is defined, by some authors, “thermo-
philic”. Levin has, however, proposed that these micro-
organisms are more correctly referred to as “thermo-
tolerant” since they do not present a real thermophilic, 
being unable to grow at temperatures equal to or above 
55° C [17]. They are also unable to grow at temperatures 
below 30° C, for the absence of the genes coding for the 
heat-shock-protein that play a role in the adaptation to 
low temperatures. Finally, it was shown that the growth 
does not occur in environments with water activity (aw) 
concentrations of less than 0.987 (sensitive to sodium 
chloride of greater than 2% w/v), while it is optimal if 
equal to 0.997 (about 0,5% w / v NaCl) [18].
Reservoirs and transmission
Campylobacter spp is a commensal germ of the gastroin-
testinal tract of many wild animals (birds such as ducks 
and gulls), farm animals (cattle and pigs) and companion 
animals (such as dogs and cats). It is, also, predominantly, 
in all avian species fit for human consumption  [19-21]. 
They are micro-organisms responsible for zoonoses and the 
transmission occurs through the fecal-oral route through in-
gestion of contaminated food and water [22-24]. The main 
environmental niche is represented by the intestinal 
tract of all avian species, particularly poultry (ie broil-
ers, laying hens, turkeys, ducks and ostriches) which is 
considered the main route of transmission [25-29]. The 
consumption of this meat, in fact, represents 50-70% 
of human cases of Campylobacteriosis [30]. However, 
even the consumption of raw milk, raw red meat, fruits 
and vegetables has been identified as a possible cause of 
transmission [31, 32]. Moore et al. have indicated that 
the prevalence of colonization by Campylobacter spp 
in cattle varies widely, even between 0-80% while it is 
around 20% in sheep [33].
Poultry
Eating or handling raw or undercooked meat of chicken 
would be the main risk factor for contracting campylo-
bacteriosis [34,35,36,37]. It was seen, in fact, that the 
feces of infected poultry may contain up to 105-108 
CFU/g. These high levels permit bacteria to spread 
easily in the environment, thus allowing the contami-
nation  [38]. Bull et al. has estimated that the chicken 
meat retail is contaminated with C. jejuni up to 98% 
of cases in the US and from 60% to 80% of cases in 
Europe [39]. Contamination occurs between the same 
farm animals, where transmission can be vertical in na-
ture (i.e. from hen to chick via egg), quite rare event, or 
horizontally within the environment where the animals 
are bred [40, 41]. The infection can be contracted in the 
very first days of life, but the presence of the organism 
in stool samples is detected no earlier than two or three 
weeks old [42]. The reason for this lag phase is still un-
known, but it could be due to the protective effect of 
maternal antibodies [43] or to the microbial flora of the 
animal itself. In the latter situation, the microbial flora 
residing in the chicken gastrointestinal apparatus could 
play a competitive role against Campylobacter, delay-
ing the colonization [44]. During slaughter, however, the 
main critical points for contamination of carcasses were 
identified in plucking, evisceration and final washing. 
The treatment with water at temperatures above 60° C, 
causes a decrease of the bacterial load which, however, 
increases during the plucking operations causing a 
cross-contamination [45, 46]. The bacterial load also can 
further increase during the evisceration due to spill of 
intestinal content rich of Campylobacter [45, 47]. More-
over, the spread of the microorganism occurs through the 
shedding into the environment of wild bird feces  [48]. 
Their presence in playgrounds has been recognized as 
an emerging environmental source of Campylobacterio-
sis, especially for children, who frequently put her hands 
to her mouth favoring the ingestion of germs [49, 50]. 
Many playgrounds are natural habitat for a variety of 
wildlife including birds, lizards, dogs and stray cats. 
New Zealand researchers have analyzed the bird fecal 
material collected in children’s playgrounds and isolated 
C. jejuni in 12.5% of samples [49].
Milk
Unpasteurized cow’s milk and dairy products are com-
mon vehicles for the transmission of Campylobacter 
spp; to identify them as a source of human Campylobac-
teriosis is already known since 1978, when four cases of 
infection by C. fetus have been identified in a hospital 
in Los Angeles County [51]. In 1996 Evans et al. has 
described an outbreak of Campylobacteriosis associated 
with the ingestion of raw milk occurs in U.K. [52]. 
Javid, later, led a study of cattle from a dairy, highlight-
ing that 12% of samples of raw milk were contaminated 
with C. jejuni [53]. The likely causes of contamination 
of milk are possible contact with bovine feces, contami-
nated water or direct contamination due to bovine mas-
titis [54, 55].
Fruits and vegetables
Numerous studies have shown the presence of C. jejuni and 
C. coli in lettuce, spinach, radishes and peas  [56-59]. It is 
likely that the contamination of vegetables to occur as a 
result of irrigation with contaminated water, use of natu-
ral fertilizers or through the same soil contaminated with 
droppings predominantly avian origin [60-62]. It is also 
possible to cross-contamination during the handling and 
packaging or through kitchen utensils used for cutting of 
other foods such as poultry [63]. Verhoeff-Bakkenes et 
al. have shown that the consumption of fruit and vegeta-
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bles, especially packaged, is an important risk factor for 
Campylobacteriosis: on 5.640 samples of fruit and vege-
tables analyzed in their survey, 13 (0.23%) were positive 
to Campylobacter, with a higher percentage (0.36%) in 
packaged products compared to fresh ones (0.07%) [31]. 
Kirk et al. and Blaser et al., in the past published two 
reports relating to two Campylobacter outbreaks caused, 
respectively, by the consumption of cucumbers served at 
a buffet [64] and the consumption of salad prepared by 
an employee of a soup kitchen from whose hands was 
isolated Campylobacter [65].
Water
European legislation provides that the natural mineral 
water obtained from springs and, occasionally, by drill-
ing sources is free from parasites and pathogens. Unlike 
the water distributed through the taps, it cannot be sub-
jected to any type of treatment that could alter its chemi-
cal composition [66]. A variety of organisms, including 
coliforms, can be found in mineral waters, in particu-
lar non-carbonated water supplied in plastic bottles and 
bottled by hand [67]; Gillespie et al., reported a case in 
which the bottled water has been identified as a possible 
vehicle for Campylobacter infection [68]. 
Swine and cattle
It is important not to underestimate the role of cattle 
and pigs that are often colonized with C. jejuni and C. 
coli [69-74].
A study carried out by Taylor et al. in the US has re-
vealed that 5% of outbreaks of Campylobacteriosis in 
the period from 1997 to 2008, was due to the consump-
tion of contaminated meat pork, beef and game [75]. 
Multiple studies have also shown that Campylobacter, 
preferentially, colonize the lower gastrointestinal tract of 
cattle [72] but has also been found in the liver, gall blad-
der and bile juice [69, 73, 74]. Moreover, there is a high-
er prevalence of Campylobacter in cattle from intensive 
farming [68%] than in adult cattle grazing (7.3%) [71]. 
This could be explained by the greater density of ani-
mals that are constantly in contact with their own faeces 
and the sharing of areas including drinking water and 
food distribution [76, 77].
As for the pigs, these appear to be predominantly colo-
nized by C. coli and, less frequently, by C. jejuni [74]; 
some studies have shown, however, the possible co-
existence, in these animals, of both the microorgan-
isms  [78, 73]. As for cattle, colonization by Campylo-
bacter in pigs was particularly notable among animals 
in intensive farming [69] than those reared in traditional 
agricultural systems [79].
Shellfish
Wilson and Moore have shown the presence of Campy-
lobacter also in molluscs, colonization due, probably, to 
the contamination of the waters in which stalling and 
are collected [80]. In this study, have been isolated ther-
motolerant Campylobacter spp in 42% of samples ana-
lyzed. The majority of these (57%) were urease-positive 
thermophilic Campylobacter (UPTC) [81,  82], with a 
clear predominance of C. lari [80]. In particular C. lari 
colonizes the intestine of seagulls that contaminate the 
water with their feces [83].
Pets
A number of domestic animals have been identified as 
hosts for Campylobacter spp [84-86]. In European and 
Asian research many Authors have reported the isolation 
of C. jejuni, C. coli, C. upsaliensis, C. helveticus, and 
C. lari from canine fecal samples [87-91]. In the United 
States, Stehr-Green et al. referred that 3% of all cases of 
salmonellosis and 15% of Campylobacteriosis can be at-
tributed to contact with pets [92]. Chaban et al. reported 
the isolation of C. jejuni in 5 dogs feces of 70 (7%) at 
concentrations up to 106 CFU/g [86]. Seeing as the in-
fective dose of C. jejuni is estimated at 500 microrgan-
isms [93], these high concentrations present in feces rep-
resent a possible risk factor for environmental contami-
nation and human infection by accidental exposure. Vet-
erinarians assume that the animal contamination could 
occur following the ingestion of raw meat [94, 95].
The transmission mode of Campylobacter from animals 
to humans have not yet been described; however, pet the 
animals and manipulate objects came into contact with 
them could transfer pathogens from the fur or object con-
taminated to the human hands and lead to infection [96].
Flies
It has been shown that even the flies represent an impor-
tant carrier for Campylobacter and they are, therefore, 
able to contaminate both humans that animals [97-99]. 
Gordon et al. have shown that some cases of diarrhea 
increased especially during the summer season when 
the larvae grow and mature by increasing the number 
of adult insects [100]. Some studies support this theory. 
Layton et al. and Neal et al. have reported the reduc-
tion of cases of diarrheal syndromes following the ap-
plication of measures for fly control [101,  102]. They 
have assumed that the transmission of the disease occurs 
by direct contact of foods with the paws, proboscis and 
body fur of the insects that were contaminated with fecal 
or regurgitated material contaminated [100]. Contami-
nation can occur at any stage of the food chain.
Epidemiology 
United States
In the US, there is an active surveillance system called 
FoodNet, which constantly monitors the spread of food-
borne diseases. In particular, the surveillance program is 
concerned of control of 7 bacterial infections confirmed 
in the laboratory (Campylobacter, Listeria, Salmonella, 
Escherichia coli O157 and non-O157 of shiga-like tox-
in producers [STEC], Shigella, Vibrio and Yersinia), 2 
parasitic infections (Cryptosporidium and Cyclospora) 
and cases of HUS. FoodNet system to belong, currently, 
10 states (Connecticut, Georgia, Maryland, Minnesota, 
New Mexico, Oregon, Tennessee, California, Colorado 
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and New York), which together make up 15% of the US 
population (48 million people in 2011) and is the result 
of a collaboration between CDC, the Departments of 
Health of the 10 Member States, the UFSA-FSIS (US 
Department of Agriculture’s Food Safety and Inspection 
Service) and the FDA (Food and Drug Administration).
According to this network [103], in 2012 were 19,531 
reported infections, 4,563 hospitalizations and 68 deaths 
associated with foodborne diseases. For most infections, 
the incidence was higher among children aged < 5 years, 
but the percentage of people hospitalized and died was 
highest among persons aged ≥ 65 years. In 2012, com-
pared to the period 2006-2008, the overall incidence of 
infections was unchanged but increased cases of infec-
tions caused by Campylobacter and Vibrio. Campylo-
bacter, in particular, ranked second, after Salmonella, as 
a cause of food-borne infections. The number of Campy-
lobacter infections (incidence per 100.000 population) 
was 6.793 [14, 30] and, of them, were typed 2.318 (34%) 
isolates of wich 2.082 (90%) were C. jejuni, and 180 
(8%) were C. coli. Estimated incidence of infection was 
higher in 2012, compared to the period 2006-2008 (up 
14% CI: 7%-21%). The percentage of hospitalized sub-
jects was 31% while the percentage of patients who died 
ranged from 0.2%.
The 2013 data confirm that the food-borne infections 
continue to be an important public health problem in the 
United States and emphasize the importance of preven-
tive measures. In particular, infections due to Campylo-
bacter spp accounted for 35% of the total, preceded by 
those due to Salmonella spp (38%).
In 2014, FoodNet has identified 19,542 cases of infec-
tion with 4,445 hospitalizations and 71 deaths. The 
crude number and incidence was 6,486/100.000.
Europe
All the data concerning the epidemiology of foodborne 
infections in the European Union (EU) are published, 
annually, by the European Food Safety Authority [EF-
SA]. EFSA’s headquarters is located in the city of Parma 
(Emilia Romagna, Italy). The data shows that in Europe 
Campylobacteriosis is, since 2005, the foodborne dis-
ease most frequently notified with over 190,000 cases 
reported each year in humans. However, it believes that 
the actual number of cases to be about nine million/year. 
In addition, according to the EFSA, the Campylobacteri-
osis cost for health systems, in terms of lost productivity, 
is approximately 2,4 billion euro per year.
In 2011 Campylobacteriosis has established itself as the 
most frequently reported zoonotic disease in humans, 
with a continuous increase of the reported cases [104]. 
In particular, a total of 220,209 cases of infection were 
reported, 2.2% more than in 2010. The food where 
Campylobacter was most found was the chicken meat. 
Despite the significant decrease in recent years, salmo-
nellosis was again the second reported zoonotic disease 
with a total of 95,548 cases. Altogether Campylobacter 
was the most frequently reported cause, it is mentioned 
less often as the cause of outbreaks of food-borne. The 
most common food sources of outbreaks were eggs and 
egg products, composite foods, fish and seafood prod-
ucts.
For the first time in five years, in 2012 human Campylo-
bacteriosis decreased slightly, but is still the most com-
monly reported zoonotic disease, responsible for 214,268 
cases of infection with a 4.3% decline compared to 2011 
[105]. The notification rate was 55.49/100,000 inhabit-
ants. Considering the high number of cases, the grav-
ity (reported deaths) was low (0.03%). Overall, 23.6% 
of fresh chicken meat samples tested were positive for 
Campylobacter spp, less than in 2011 in which was posi-
tive for 31.3% of the samples.
Campylobacter spp in 2013 continued to be the most 
commonly reported gastrointestinal pathogen in the 
European Union (EU). The number of confirmed cases 
reported was 214,779, with an EU notification rate of 
64.8/100,000, the same level of 2012  [106]. Mortality 
was low (0,05%). Overall, 31.4% of fresh chicken meat 
samples checked were positive for Campylobacter spp. 
In the period 2012-2013, this increase in Campylobac-
ter-positive samples was mainly due to the placing of the 
data coming from Croatia, which reported results for the 
first time in 2013. Campylobacter it was also detected 
less frequently in the flesh of turkey and other foods. 
In 2013, moreover, they have been reported from 414 
Campylobacter outbreaks. The sources of these out-
breaks were, in order of importance, chicken meat and 
dairy products and other foods such as milk and mixed 
foods.
Italy
In Italy, the latest data available on Campylobacteriosis 
concern 2006 with 476 isolations of Campylobacter spp 
from clinical specimens that have been reported by the 
laboratories of the Enter-net network. In 73,9% of cases 
the laboratories carried out the identification of species. 
C. jejuni was the most frequently isolated species. 35,5% 
of strains were isolated from pediatric patients under the 
age of 6 years, especially in the summer months. The 
presence of antimicrobial-resistant strains is high in par-
ticular for quinolones and fluoroquinolones [107].
Pathogenesis and virulence factors
Colonization and intestinal epithelium adherence are the 
first and indispensable stages of the disease pathogene-
sis. For this reason, the characteristic motility of the bac-
terium by polar flagella that the cell possesses is funda-
mental [108]. The flagella determine a rotational propul-
sive movement of the cell body while the helical shape 
determines a typical movement like a corkscrew [109]. 
The intestinal epithelium colonization is secondary to a 
chemotaxis process in which the main chemoattractors 
are the mucins and glycoproteins constituting the intes-
tinal mucus [110]. The main bacterial chemoceptors are 
represented by proteins called What A, B, R, W, Y and 
Z [111].
The subsequent bacterial adhesion to the intestinal epi-
thelial surface is mediated by several adhesins placed 
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on the surface of the bacterium [112]. In particular, a 
key role is played by an external membrane protein 
that binds the fibronectin named CADF [113] and by a 
protein called CapA or protein of Campylobacter Ad-
hesion [112]. The consequent cell damage is related to 
the production of various cytotoxins [114,  115]. The 
most studied Cytotoxin is the CDT or Cytolethal Dis-
tending Toxin [116]. This toxin has desoxyribonuclease 
activity and determines the cell cycle block in the G2 
phase [116] and fragmentation of the nucleus resulting 
in cell death [117].
Clinical manifestations and related 
complications
The clinical spectrum of Campylobacter varied from a wa-
tery diarrhea without blood to a severe inflammatory diar-
rhea with abdominal pain and fever. The disease appears 
to be less severe in developing countries than in indus-
trialized countries [118, 119]. In detail, in industrialized 
countries, the clinical picture is generally characterized by 
bloody stools, fever and abdominal pain and is often more 
severe than that caused by Salmonella and Shigella spp, 
in developing countries, instead, the symptoms are gener-
ally represented by watery stools with leukocytes, fever, 
abdominal pain, vomiting, dehydration [120,  121]. The 
Campylobacter spp infection can be burdened by some 
major complications. The main recognized sequelae are 
Guillain-Barré Syndrome (GBS), the Reactive Arthritis 
(REA) and irritable bowel syndrome. The Miller Fisher 
Syndrome, a variant of GBS, can also be associated with 
a previous Campylobacter infection. Evidence suggest a 
possible association with Inflammatory Bowel Disease 
(IBD), and there is evidence that other functional gastro-
intestinal disorders may be related to gastroenteritis in 
general (not specifically caused by Campylobacter). This 
aftermath, of course, they contribute significantly to the 
burden of disease [122]. 
Guillain-Barré Syndrome
The role of Campylobacter spp has now been exten-
sively studied in triggering an autoimmune response that 
leads to damage of the peripheral nervous system and 
the development of GBS. The Campylobacter-induced 
GBS is now considered a real disease and it seems that 
the basis of its unleashing there is the phenomenon of 
molecular mimicry. There are quite comprehensive data 
on the incidence of GBS in Europe and North Ameri-
ca  [123,  124]. The disease has also been well studied 
in China [125] and Japan [126], but the population in-
cidence data are still scarce. The data on the worldwide 
incidence of GBS are limited with regard to low-income 
countries standards. In Bangladesh a recent publica-
tion reports that the disease has a higher incidence, and 
the presence at a young age, compared to high-income 
countries [127]. The lack of a common definition of 
GBS hampers the comparability of data and uniform-
ity in the notification. Recently, there has been proposed 
guidance for a standardized definition of the clinical 
case of GBS, the so-called “Brighton criteria” that are 
receiving broad international support [128]. Globally, 
around a third of cases of GBS have been attributed to 
a previous Campylobacter spp infection [129]. A link 
between reduced incidence of Campylobacteriosis and 
reduced incidence of GBS has been reported in New 
Zealand [130]. A link between reduced incidence of 
Campylobacteriosis and reduced incidence of GBS has 
been reported in New Zealand [130]. Some researchers 
have studied the clinical course of GBS and have shown 
that cases of GBS preceded by Campylobacter spp in-
fection are more severe and are characterized by poorer 
therapeutic results with long-term possibility of disabil-
ity [131, 132]. Treatment of the disease includes a gen-
eral multidisciplinary assistance and specific treatment 
with plasmapheresis and/or intravenous immunoglobu-
lin. Approximately 20% of patients is hospitalized in an 
intensive care unit to support ventilation and to monitor 
the autonomic dysfunction. Access to optimal treatment, 
however, varies greatly around the world, especially in 
less developed countries, where the GBS remains a seri-
ous and potentially fatal disease. The fatality rates vary 
widely and range between 3% and 10% in high-income 
countries while the lethality in countries developing is 
assumed to be higher. A recent meta-analysis concluded 
that as many as 31% of GBS cases could be attributed to 
Campylobacter spp [129]. This meta-analysis was based 
on studies conducted mainly in high-income countries 
and China and India, while it was only considered a 
study conducted in a country classified by the US as 
“less developed.” A more recent study in Bangladesh 
showed that 57% of cases of GBS could be attributed to 
Campylobacter spp [133].
Reactive arthritis
Available data suggest that reactive arthritis occurs 1-5% 
of individuals infected with Campylobacter spp. The an-
nual incidence of REA after Campylobacter spp infec-
tion is estimated at 4.3 per 100,000 inhabitants in high-
income countries [134]. In a study, in 5% of subjects 
the resulting reactive arthritis to Campylobacter spp in-
fection is found to be chronic or recurrent [135]. There 
is evidence that musculoskeletal disorders can be trig-
gered by Campylobacter and other enteric infections. In 
a US study published in 2008 and conducted by Townes 
et al. [136] in Minnesota and Oregon, the individuals 
with positive stool culture for Campylobacter spp, Sal-
monella spp, Shigella spp, Yersinia spp and Escherichia 
coli O157 were followed for 8 weeks. In particular, they 
were monitored 6379 patients with a confirmed infec-
tion; of these, 70% have completed screening and 575 
(13%) have developed reactive arthritis. Other studies 
have reported a long-term disabilities resulting reactive 
arthritis. Hannu et al.  [137] have estimated that 25% 
of patients with reactive arthritis can develop a chronic 
spondylo-arthropathy, with different manifestations.
Irritable bowel syndrome [IBS]
The infectious gastroenteritis is one of the major pre-
disposing factors for the development of IBS [138, 139]. 
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Some studies have reported that up to 36% of individu-
als with acute Campylobacteriosis develop IBS within 
1-2 years [140]. There seems to be a close correlation 
between risk of developing IBS and the severity of 
the acute illness. Following an outbreak of infection 
with Campylobacter spp and Enteromorragic E. coli 
(EHEC) caused by contaminated water, Marshall et al. 
have reported an increased risk of IBS among those 
who had had a greater length of diarrhea, dysentery 
and abdominal cramps during the acute phase of the 
disease [141]. The studies carried out on patients with 
IBS post-Campylobacter infection have shown an in-
crease of intraepithelial lymphocytes and upregula-
tion of cytokines in colon-rectal mucosa, typical of a 
persistent immune activation [142-145]. The intestinal 
inflammation and hyperplasia of enterochromaffin 
cells in IBS post-infection are also accompanied by 
an increase in intestinal permeability resulting in an 
increase in the antigenic load and further activation of 
the immune system [146].
Other functional gastrointestinal disorders 
related to CampylobaCter
Scientific evidence linking infectious diarrheal syn-
dromes with other functional gastrointestinal disorders 
such as functional dyspepsia. Mearin et al. [147] and 
Porter et al. [148] have reported an association between 
infectious diarrhea invasive, respectively Salmonella 
spp and from all causes, and post-infectious function-
al dyspepsia (OR 5,2 and 5,0, respectively). Similarly, 
Parry et al. showed an increase of 2,9 times of func-
tional dyspepsia resulting in bacterial gastroenteritis 
(including Campylobacter) compared to non-exposed 
controls [149]. A further study also identified a link be-
tween acute enteric infection and functional dyspepsia 
in children [150]. It seems that there is lastly a relation-
ship between the presence of Campylobacter and other 
functional gastrointestinal disorders such as diarrhea, 
functional constipation and gastro-oesophageal reflux 
disease [151, 152].
Inflammatory bowel disease (IBD)
In recent years, it has strengthened the hypothesis of 
an association between IBD and acute diarrheal infec-
tion caused by Campylobacter. The first studies that de-
scribed the possible association between acute infection 
and inflammatory bowel disease date back to the ‘90s; 
Schumacher, for example, observed that cases of travel-
er’s diarrhea were associated with a first attack of IBD in 
62% of patients [153]. Campylobacter was isolated from 
10% of cases of IBD relapsing [154]. Recent cohort stud-
ies have shown a higher risk of developing IBD follow-
ing an acute infection with Campylobacte  [155  156].
A study by Garcia-Rodriguez et al., Published in 2006, 
showed that the risk of developing IBD has increased af-
ter a year by an episode of acute gastroenteritis, with an 
incidence of 60 cases per 100,000 inhabitants-year [157]. 
The pathogenesis of post-infectious IBD remains un-
clear. At the base there appears to be an enhanced host 
immune response to intestinal microbiome [158] due to 
an increased absorption of bacterial antigens second-
ary to increased intestinal permeability that residual, as 
damage, after the infectious episode [157].
Laboratory diagnosis
The conventional method for the isolation of Campylo-
bacter species in stool is represented by seeding the sam-
ple on selective media followed by incubation at 42° C 
in microaerophilic environment (5% O2, 10% CO2, 85% 
N2). Some species (C. sputorum, C. concisus, C. mu-
cosalis, C. curvus, C. rectus and C. hyointestinalis) for 
isolation may require the additional presence of hydro-
gen [159]. Media used, made selective in order to sup-
press the competitive bacteria and promote the growth of 
Campylobacter spp may be added to blood or coal, both 
of which contain one or more antibiotics.
The most commonly used culture media between those 
that contain blood, are the selective medium of Butzler 
(sheep blood agar to 10% with bacitracin, novobiocin, 
colistin, cephalothin and actidione), the Blaser media 
(agar-blood sheep to 10% with vancomycin, trimetho-
prim, polymyxin B, cephalothin, and amphotericin B) 
and the Skirrow media (horse blood agar lysate to 7% 
with vancomycin, polymyxin B and trimethoprim). 
Among media with coal the most used is certainly the 
Preston medium, containing cefoperazone. Merino et 
al. [160] have shown that the latter is the best in the re-
covery of the higher number of germs from fecal mate-
rial.
It recently launched a selective chromogenic medium for 
Campylobacter (CASA Agar), which greatly facilitates 
the isolation and detection of these bacteria. On CASA 
agar, there is a strong inhibition of the growth of com-
petitive intestinal flora while the colonies of Campylo-
bacter spp are red and easily recognized [161]. Often the 
various species of Campylobacter isolated from human 
samples are not easily identifiable. Only C. jejuni can be 
identified with the use of phenotypic markers such as the 
morphological appearance of the colonies, biochemical 
reactions and optimal growth temperature; the other spe-
cies require a polyphasic approach, using a combination 
of phenotypic and molecular markers.
In most clinical laboratories, even the identification of 
Campylobacter spp is performed only at the level of ge-
nus. The MALDI-TOF MS (Matrix Assisted Laser De-
sorption Ionization-Time of Flight Mass Spectrometry) 
represents a new and interesting means of identification 
of Campylobacter spp, despite not provide information 
on bacterial resistance and lacks a computer system able 
to suggest other tests additional [162]. They were finally 
developed molecular assays using species-specific reac-
tions or multiplexes, based on 16S rRNA gene sequenc-
es, or other species-specific gene sequences and identi-
fication systems based on microarray. All these systems 
can provide valuable support in official laboratories for 
Public Health and Food Safety [163, 164].
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Antibiotic-resistance
In 2010 in the United States, only 1% of the strains of C. 
jejuni isolates from human infections were resistant to 
erythromycin, while 43% were resistant to tetracycline 
and 22% to ciprofloxacin  [165]. In the same year, the 
FDA has reported almost overlapping data observed in 
strains of C. jejuni isolates from chicken meat [166].
In 2010 In the European Union 2% of C. jejuni from 
humans were resistant to erythromycin, 21% to tetracy-
cline and 52% to fluoroquinolones; in strains isolated 
from chicken meat values were 2%, 22% and 50%, re-
spectively. Both in the US than in Europe, the antibiotic 
resistance is greater in C. coli than in C. jejuni [167].
The cause of high resistance to fluoroquinolones appears 
to be the habitual use of veterinary antibiotics (enrofloxa-
cin and danofloxacin) in the pharmacological treatment of 
poultry [168]. Because of this, in the United States the use 
of fluoroquinolones in poultry authorization was with-
drawn in 2005 [169]. In Australia, where this use has not 
been approved, the resistance to these drugs is rare [168]. 
It was noted that infections resistant to fluoroquinolones 
are often associated with travel in both developed coun-
tries and in developing countries [170-172].
A recent study published in 2015 by Ghunaim et 
al. [173] shows an erythromycin resistance of C. jejuni, 
relatively low: only 8,6% of the isolates were resistant, 
while 63.2% were resistant to ciprofloxacin. A high rate 
of resistance to ciprofloxacin was also reported in the 
UAE, where 85,4% of the isolates were resistant [174]; 
in Poland they were published [175] lower rates of re-
sistance (40%) and only 2% in Australia [176].
Prevention
There are numerous ways to prevent this infection, in-
cluding vaccination and poultry control.
Health surveillance
According to Thacker S. the “Health Monitoring” is the 
systematic collection, analysis and interpretation of data 
on specific diseases within a determinate population 
in order to guide the actions and decisions in the field 
of Public Health [177]. A well-structured surveillance 
program for Campylobacteriosis can provide crucial in-
formation about the importance and the presence of the 
disease than other enteric infections contributing, also, 
to identify the most common routes of pathogen trans-
mission. A complete surveillance of Campylobacteriosis 
should be carried out at national level, with data from 
all regions, including notifications of cases and the mi-
crobiological data typing of strains isolated from both 
human cases and from cases animals. Alternatively, they 
could be monitored specific sentinel sites, adequately 
resourced, and broadly representative of the whole 
country. In New Zealand, a hybrid approach unifies the 
national data of reported cases, and the epidemiological 
information related to supervision of sentinel sites [178]. 
Vaccination
The WHO recognizes a considerable potential in anti-
Campylobacter vaccines for both humans and animals. 
In humans, in particular, this potential concerns the pre-
vention not only of acute infection but also of sequelae, 
with a remarkably reduction of patients. It is unlikely 
that a vaccine can be used for preventive purposes on 
a large scale, but it could be important for those who 
are at greatest risk. However, you still need consider-
able research before this can be achieved. Currently 
there are still no approved vaccines against diarrhea as-
sociated with Campylobacter. The development of ef-
fective vaccines against C. jejuni is limited by incom-
plete understanding of the pathogenic mechanisms of 
the disease and the strong association of this with GBS. 
Most strains of C. jejuni produces lipo-oligosaccharide 
(LOS) that contain sialic acid (Neu5Ac) with a structure 
very similar to human gangliosides. Antibodies directed 
against these molecules can cross-react with human pe-
ripheral nerves causing the establishment of GBS. This 
association between C. jejuni and GBS preclude many 
vaccination approaches. However, the recent discovery 
that C. jejuni (unlike other enteric pathogens) expresses 
a capsular polysaccharide (CPS) has favored the creation 
of a CPS-conjugate vaccine similar to those that have 
been developed for other pathogens [179]. Although few 
details are known of the molecular pathogenesis of the 
disease, the invasion of the intestinal epithelial cells ap-
pears to be a critical stage, and the PSC appears to play 
an important role in adherence to the cells. Thus, anti-
bodies against the CPS may induce a protective immune 
response. Also, unlike the LOS, there is no evidence of 
molecular mimicry of the PSC with human gangliosides 
and, therefore, the antibodies should not trigger autoim-
mune reactions. There is no reason to think that vacci-
nation could prevent, in the future, the development of 
Campylobacter-associated GBS. A common problem 
associated with capsular vaccines is the poor immuno-
genicity particularly in infants, a population to which 
many of these vaccines are directed. This occurs because 
polysaccharides are cells T-independent antigens and are 
able to stimulate only the mature B cells. However, the 
conjugation of polysaccharide with proteins transforms 
the immunological response from T-cell-independent to 
T-cell-dependent leading to the development of immu-
nological memory both in children and in adults [180].
Control measures in poultry
All types of poultry can be colonized with Campylo-
bacter spp [181]. Vertical transmission of the bacterium 
through eggs is an extremely rare event [182]. The vast 
majority of broiler chickens are free of Campylobacter 
in the day of egg hatching, which means that at the be-
ginning, each new group of chickens is Campylobac-
ter-free. Once the Campylobacter is introduced into a 
group, it spread with the faeces rapidly colonizing al-
most all animals (up to 108 Campylobacter/gr faeces). 
The colonization rate remains almost at the same level 
until the age of slaughter (42 days in conventional pro-
duction systems).
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Colonization does not determine the onset of clinical 
signs or a reduction of the life of infected individuals. 
The broiler chickens can be colonized with C. jejuni and 
C. coli. However, approximately in 6 weeks old chickens, 
most of the isolated strains is represented by C. jejuni 
while in older animals predominates C. coli [183, 184].
In literature there are many articles about the possible 
actions to be taken to control chickens contamination by 
Campylobacter both on farms than in slaughter and pro-
cessing houses.
There are considerable differences in the production of 
poultry in different parts of the world as a type of estab-
lishment (indoor or outdoor), the equipment used for the 
supply of food and water, the type of litter used (new or 
reused between groups), the microclimate, the method 
of ventilation and, finally, breed of chickens used. These 
differences will have a weight on the effectiveness of 
preventive interventions and determine on which inter-
ventions should be emphasized in order to achieve the 
greatest risk reduction.
Although the Campylobacter spp contamination control 
is a global problem, each country must develop its own 
strategies for achieving it. The only intervention proved 
to be effective in preventing the introduction of Campy-
lobacter spp in the establishments of production is the 
application of strict biosecurity measures  [185,  186]. 
They include:
• a strict control of establishment access to minimize 
the entry of unauthorized persons, birds, rodents or 
other animals;
• an insect control (e.g., flies and cockroach-
es) [187, 190];
• a workers’ control (such as the introduction of hy-
giene barriers and the change of footwear before en-
tering in the plant) [191];
• water purifying (chlorination) [191];
• control of litter and waste, avoiding the exchange be-
tween the groups [192, 193];
• other animals and rodents control [194];
• disinfection of cleaning tools [195];
• cleaning and disinfection of the whole plant and of 
all the equipments [190].
There are, moreover, a whole series of other interven-
tions “pre-harvest” that have been successful in the field 
of research, but that have not yet proven effective when 
applying. They include the use of bacteriocins, bacterio-
phages, organic and inorganic acids in the feed or drink-
ing water. However, the advantage of an intervention on 
the field can be lost if there is no simultaneous action in 
the transportation from the farm to processing establish-
ments that reduce cross-contamination [195, 196].
Other important phases are selection of the animals, 
transport to the slaughterhouse, time spent in the slaugh-
ter facility [187]. The removal of the feed and water prior 
to the collection of animals has a significant impact on 
the Campylobacter load because may contaminate the 
animals during the transport and in the treatment plant. 
This is considered an integral part of the post-harvest 
control. Even at this stage, a good hygiene is crucial to 
the success of the control procedures [188-190]. Appro-
priate measures include cleaning, disinfection and dry-
ing of transport tools, cages and coops, a proper stock-
ing density, sanitize surfaces and liquids used (heaters, 
coolers, etc.) that come in contact with each carcass in 
order to reduce cross-contamination, and the use of spe-
cific food safety protocols as the application of good 
hygiene practices. Carcass decontamination by physi-
cal or chemical means is the procedure with the greatest 
chance of success among all post-harvest interventions 
proposed  [191,  192]. The methods include the use of 
large volumes of water to wash carcasses, countercurrent 
flow of water in the heaters and water coolers, freezing 
of carcasses, treatment of carcasses with heat (steam) or 
irradiation. The chemical decontamination includes the 
use of chlorine compounds, organic acids, ozone, per-
acetic acid, peracetic acid with hydrogen peroxide, triso-
dium phosphate, as well as some “natural” methods such 
as the use of bacteriophages and bacteriocins.
Finally, the meat is likely to be contaminated even when 
it comes on the market. At this time, it is essential that 
the control measures are extended to distributors, retail-
ers and end-consumers. As with any raw product, good 
hygiene practices are required during the preparation, 
storage and distribution of food. These practices include 
washing hands before and after handling food; the han-
dling raw and cooked food; it is important to keep raw 
meats separate from cooked or ready to eat food; avoid 
using the same utensils to handle raw meats and oth-
er foods (such as cutting boards and/or other surfaces, 
knives and dishes); wash and disinfect all surfaces and 
utensils that have been in contact with raw meat; do not 
wash with tap water the raw meat in order to avoid fur-
ther spread of microorganisms in the working surfaces. 
Because, finally, Campylobacter is sensitive to cooking 
temperatures, cook the food at 70° C will minimize the 
risk of contracting the infection.
Conclusions
Evaluating the epidemiology of Campylobacteriosis we 
have revealed an increasingly important role for Campy-
lobacter infection in Public Health. While global efforts 
to control the transmission of enteric pathogens have 
been effective at reducing the incidence of a number of 
major foodborne pathogens, the human Campylobacter 
infections have been increasing in the last decade with a 
prevalence of infection ever increasing across most de-
veloped nations. Many progresses have been made in di-
agnostics that are helping to refine estimates of the acute 
and long-term burden of disease associated with a broad 
range of Campylobacter spp. We assume that better and 
efficient applied assays are necessary for an improved 
understanding of the epidemiology of different Campy-
lobacter spp and to allow vaccine development. We also 
believe that it is necessary, due to growing antimicrobial 
resistance, implement control strategies on their use. 
Furthermore, it is now well established that poultry and 
other domesticated animals, such as cattle and pigs, and 
environmental sources, such as contaminated water, also 
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play a vital role in the direct transmission of these organ-
isms to humans. For this reason, it is very important the 
realization of standardized biocontrol methodologies in 
the poultry sector, a principal source mediating Campy-
lobacter transmission to humans. 
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